Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Alembic
FDA Approves DAPAGLIFLOZIN — Alembic Pharmaceuticals Limited

# FDA Approves Generic Dapagliflozin from Alembic Pharmaceuticals The U.S. FDA has approved Alembic Pharmaceuticals Limited's generic dapagliflozin o...

Sun
FDA Approves DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Sun Pharmaceutical Industries, Inc.

Sun Pharmaceutical Industries, Inc. secured FDA approval for its oral generic Dapagliflozin and Metformin Hydrochloride tablets, positioning the compa...

Cipla
FDA Approves DAPAGLIFLOZIN — Cipla USA Inc.

Cipla USA Inc. secured FDA approval for its generic oral tablet of Dapagliflozin, positioning the manufacturer to capture market share in the growing ...

Biocon
FDA Approves DAPAGLIFLOZIN — Biocon Pharma Inc.

Biocon Pharma Inc. secured FDA approval for its generic oral formulation of Dapagliflozin via ANDA211470, with the product slated for a market entry i...

Ascend
FDA Approves DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Ascend Laboratories, LLC

Ascend Laboratories received FDA approval for its Generic Dapagliflozin and Metformin Hydrochloride tablets, a critical oral combination therapy for t...

Apotex
FDA Approves DAPAGLIFLOZIN — Apotex Corp.

The FDA has granted full approval to generic dapagliflozin manufactured by Apotex Corp., paving the way for the company to capture market share in the...

Aurobindo
FDA Approves DAPAGLIFLOZIN — Aurobindo Pharma Limited

Aurobindo Pharma Limited announced the approval of its ANDA for dapagliflozin, granting it rights to manufacture and market this generic oral product ...

Baxter
FDA Approves PHENYLEPHRINE HYDROCHLORIDE — Baxter Healthcare Corporation

# FDA Approves Baxter Healthcare's Generic Phenylephrine Hydrochloride Injection Baxter Healthcare Corporation has received FDA approval for its gene...

Sandoz
FDA Approves NINTEDANIB — Sandoz Inc

# FDA Approves Sandoz's Generic Nintedanib, Expanding Competition in Pulmonary Fibrosis Market Sandoz Inc. has received FDA approval for its generic ...

Dr.
FDA Approves NINTEDANIB — Dr. Reddy's Laboratories Inc.

# FDA Approves Dr. Reddy's Laboratories' Generic Nintedanib Dr. Reddy's Laboratories Inc. received FDA approval for its generic nintedanib esylate or...

Apotex
FDA Approves NINTEDANIB — Apotex Corp.

# FDA Approves Generic Version of Nintedanib, Enabling Significant Cost Savings for Pulmonary Fibrosis Patients Apotex Corp. has received FDA approva...

EXELAN
FDA Approves NINTEDANIB CAPSULES, 100 MG AND 150 MG — EXELAN PHARMACEUTICALS INC.

# FDA Approves Generic Nintedanib Capsules; Exelan Pharmaceuticals Enters Competitive Pulmonary Fibrosis Market Exelan Pharmaceuticals Inc. has recei...

Edenbridge
FDA Approves NINTEDANIB — Edenbridge Pharmaceuticals LLC.

Edenbridge Pharmaceuticals LLC has received FDA approval for its ANDA219819 application for Nintedanib Esyslate tablets, strengthening the firm’s port...

Eli
FDA Approves FOUNDAYO — Eli Lilly and Company

# FDA Approves Eli Lilly's FOUNDAYO for Oral Administration Eli Lilly and Company received FDA approval for FOUNDAYO (orforglipron calcium), an oral ...

KLM
FDA Approves MESALAMINE — KLM Laboratories Private Limited

# FDA Approves KLM Laboratories' Generic Mesalamine Rectal Formulation KLM Laboratories Private Limited received FDA approval for its generic mesalam...

ScieGen
FDA Approves OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — ScieGen Pharmaceuticals Inc

# FDA Approves Generic Olmesartan Medoxomil and Hydrochlorothiazide Combination ScieGen Pharmaceuticals Inc received FDA approval for a generic versi...

Baxter
FDA Approves EPINEPHRINE — Baxter Healthcare Corporation

# FDA Approves Baxter Healthcare's Intramuscular Epinephrine Formulation Baxter Healthcare Corporation received FDA approval for its intramuscular ep...

TEVA
FDA Approves Unknown Drug — TEVA PHARMACEUTICALS, INC.

On March 27, 2026, Teva Pharmaceutical Industries received FDA approval for unspecified new agents contained in BLA761385, a milestone that signals th...

SAGENT
FDA Approves Unknown Drug — SAGENT

On March 26, 2026, SAGENT received FDA approval for a new drug, signaling a strategic entry into the market with potential to compete against existing...

Denali
FDA Approves AVLAYAH — Denali Therapeutics Inc.

# FDA Approves Denali Therapeutics' AVLAYAH, Expanding Its Neurology Portfolio Denali Therapeutics Inc. received FDA approval for AVLAYAH (tividenofu...